Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus

Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.

Genes and immunity·2006

Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

Clinical and experimental immunology·2006

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Immunity·2002

Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis.

Pathology international·2002

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus.

Immunity·2001

Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice.

Journal of immunology (Baltimore, Md. : 1950)·2001

Targeting IFN signaling as therapeutic option for lupus nephritis.

Autoimmunity·2026

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Autoimmunity·2026

Compound kushen injection inhibits immune evasion of hepatocellular carcinoma cells via reducing O-GlcNAcylation of Pd-L1.

Autoimmunity·2026

E4BP4 restrains effector-memory CD8+ T cell responses in systemic lupus erythematosus.

Autoimmunity·2026

Investigating and validating the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development based on single-cell, bulk transcriptomics, and RT-qPCR.

Autoimmunity·2026

Interferon regulatory factor 1 mediates ROS-dependent release of NETs in LPS-induced mouse pneumonia by interacting with matrix metalloproteinase 9.

Autoimmunity·2026

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

Expert opinion on biological therapy·2026

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatology (Oxford, England)·2026

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Immunological medicine·2026

Related Experiment Videos

Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus

Related Concept Videos

Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.

Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis.

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus.

Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice.

Targeting IFN signaling as therapeutic option for lupus nephritis.

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Compound kushen injection inhibits immune evasion of hepatocellular carcinoma cells via reducing O-GlcNAcylation of Pd-L1.

E4BP4 restrains effector-memory CD8+ T cell responses in systemic lupus erythematosus.

Investigating and validating the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development based on single-cell, bulk transcriptomics, and RT-qPCR.

Interferon regulatory factor 1 mediates ROS-dependent release of NETs in LPS-induced mouse pneumonia by interacting with matrix metalloproteinase 9.

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Related Experiment Videos

Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus

Related Concept Videos

Related Articles